Introduction
Hypertension (HTN) presents the most significant cardiovascular risk factors and could affect one-third of adult population [1, 2] . Resistant HTN represents ∼20-30% of all HTN patients, and is defined by ESH/ESC in 2013 as a clinical situation in which lifestyle changes plus pharmacologic treatment with three drugs (including a diuretic) fail to lower the blood pressure (BP) to below 140/90 mmHg [3] . Cardiovascular complications along with end organ damage are higher in patients with resistant HTN than the controlled ones [4] . Over the past 15 years, the recommendations are to do a systematic search for secondary causes of HTN as it may be reversible cause for that resistant HTN [5] . At the same time, HTN owing to secondary causes is believed to be more common in patients with resistant HTN than in controlled HTN ones [6] . Gonçalves et al. [7] showed that the prevalence of obstructive sleep apnea (OSA) in resistant HTN may be approaching 70-83%. OSA has been associated with long-term consequences. Over the past decade, there have been multiple research studies on the relation between OSA and HTN, and their combined treatments should be deemed in cases with refractory resistant HTN [8] [9] [10] . Causal and bidirectional relationships between OSA and HTN along with its pathophysiologic features have been described by experimental studies [11] . The relation between OSA and HTN has been studied through many study designs owing to its prognostic effect [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . Through many mechanisms, OSA may result in left ventricular hypertrophy (LVH) [29] [30] [31] [32] . Limited data are available regarding the frequency of OSA in Egyptian patients with resistant HTN and its effects on left-sided systolic and diastolic function.
Materials and methods

Study population
This study was done as a case-control study and included 88 patients diagnosed to have essential HTN (44 patients have resistant HTN as a case group and 44 patients have controlled HTN as a control group) in Sleep Laboratory Unit, Chest Department, Kasr Alini Hospital, Cairo University, after approval of the ethical committee from January 2017 to January 2018, with specific inclusion and exclusion criteria applied.
Patients with resistant HTN, defined by the American Heart association criteria of 2017, were included. The criteria define resistant HTN as 'office BP more than 140/90 and the patient prescribed three or more antihypertensive medications at optimal doses, including if possible a diuretic, or office BP at goal but the patient requiring four or more antihypertensive medications.' Patients with the following criteria have been excluded: (a) pseudo-resistance, which mean that the patient is not compliant with prescribed regimen, (b) congestive heart failure, (c) valvular heart diseases, (d) diabetes mellitus, (e) patients with chronic obstructive pulmonary disease (COPD), (f) current smokers, (g) chronic kidney disease, (h) possible renal artery stenosis, (i) possible pheochromocytoma, and (j) possible Cushing's syndrome.
All the patients have undergone meticulous history taking, including demographic data, documented duration, severity, and progression of the HTN, treatment adherence, response to prior medications, and adverse events.
Moreover, screening for the current drugs, including herbal and over-the-counter use, that may affect HTN was done. All patients have been examined thoroughly to exclude any possible cause of secondary HTN. The American heart association recommendations regarding BP measurement was followed. 'The AHA recommends that the patient should be seated and relaxed with legs uncrossed and back with arm to be supported, and also advised the patient to be seated 5 min before the BP reading. At least two readings with 1 min apart should be recorded, and average should be taken. The arm should be supported at the heart level during the cuff measurement. At the first visit, the highest pressure has been recorded after measuring BP into both arms (AHA 2005) [33] .
Epworth sleepiness scale [34] , STOP-BANG questionnaire [35] , BMI, and neck and waist circumference were measured. Full kidney function tests, lipid profile, albumin-creatinine ratio, serum beta naturaitic peptide (BNP), ECG, and abdomen and pelvic ultrasound to exclude chronic renal disease if all other investigations are in borderline range were also conducted. Both Epworth sleepiness scale [34] and STOP-BANG questionnaire [35] are shown in (Figure 1 and 2), respectively.
Polysomnography and echocardiographic measurements
Echo cardiography was done by the same cardiologist using the same machine (VIVID E9; GE, USA) to avoid the bias by different operators and devices. It was used to assess the systolic and diastolic function of the heart, with stress on the following parameters: (a) the left ventricular end diastolic volume, which ranges between 3.5 and 5.7 cm; (b) the left ventricular end systolic volume, which ranges between 2.2 and 4 cm; (c) the interventricular septal diameter in diastole; (d) the posterior wall diameter in diastole; (e) the size of left atrium, which ranges between 1.9 and 4 cm; (f) the ejection fraction, which normally ranges between 55 and 80%; (g) the left ventricular mass index (LVMI) with the following levels; (h) the presence of left diastolic dysfunction with calculation of the mitral inflow wave (E/A) wave, the mean E′ (average of septal wall and lateral wall), and the E/mean E′. Table 1 shows the reference ranges of LVMI.
LV mass was calculated according to the following formula:
where IVSd is intraventricular septal thickness in diastole in cm, LVIDd is the left ventricular diameter in diastole (cm), and PWTd is the posterior wall thickness in diastole. This was then divided by body surface area to give LVMI [36] .
Tissue Doppler E/E′ is an estimate of left atrial filling pressure, may predict primary cardiac events in a hypertensive population, and is considered an effective simple noninvasive tool to estimate cardiac risk in these patients group [37] .
Then screening and workup for detection of diastolic heart failure was done, which consists of demonstration of structural and/or functional alterations of the heart. The structural alterations include a LVMI of at least 115 g/m 2 for males and more than or equal to 95 g/m 2 for females. Key functional alterations include an E/e′? of at least 13 and a mean e' septal and lateral wall of more than or equal to 9 cm/s [38] . Polysomnography type II was done using the SOMNO medics (D-97236; GmbH, Randersacker, Germany) machine, where apnea hypopnea index (AHI), lowest SpO 2 , duration of lowest SpO 2 in seconds, time in bed (%TIB), SpO 2 less than 90%, and duration of SpO 2 less than 90% in minutes were recorded for all patients. American academy of sleep medicine criteria of 2008 has been used as a reference. It categorized OSA into mild (AHI 5-15), moderate (AHI 15-30), and severe (AHI>30) [39] . Reference and index of OSA you used in your results.
Statistical analysis
Data were coded and entered through the statistical package statistical package for the social sciences (SPSS) version 25. Data were summarized using mean, median, minimum, and maximum with SD in quantitative data, whereas for categorical data using frequency (count) and relative frequency (percentage). Kruskal-Wallis and Mann-Whitney tests were used for comparisons between quantitative variables [40] , whereas χ 2 -test was used for comparing categorical data [41] . Spearman correlation coefficient was used for correlations between quantitative variables [42] . When P values were less than 0.05, it was represented as statistically significant.
Results
This study was done as a case-control study and included 88 patients diagnosed to have essential HTN (44 patients have resistant HTN as a case group and 44 patients have controlled HTN as a control group) in Sleep Laboratory Unit, Chest Department, Kasr Alini Hospital, Cairo University, after approval of the ethical committee from January 2017 to January 2018. Comparison between both groups regarding the percentage of OSA and its severity is shown in ( AHI, apnea hypopnea index. STOP-BANG questionnaire.
P<0.001; and 122.45±17.45 and 113.09±13.06, P=0.009, respectively). Table 3 shows that the average BP readings (systole and diastole) and the number of medications of HTN were higher in case group with significant statistical difference, but there were no significant statistical differences between both groups regarding duration of HTN (in years). This study detected statistically significant difference between both groups regarding STOP-BANG questionnaire. No difference between the case group and control one was noted during ESS assessment. Comparison between both groups regarding polysomnographic data is shown in (Table 4) , where AHI, hypopnea, lowest SpO2, %TIB less than 90%, and the duration of SpO 2 less than 90% in minutes had significant statistical difference between both groups, whereas for the heart rate, there was no significant difference. Our study showed that the ejection fraction % had no statistically significant difference between both groups. Table 5 shows the comparison between both groups regarding the echo heart parameters; the LVMI was higher in patients with resistant HTN/ OSA than patients with controlled HTN/OSA, with significant statistical difference. Moreover, the table shows that the majority of both patients with resistant HTN/OSA and patients with controlled HTN/OSA do not have evidence of diastolic heart failure or diastolic dysfunction (81.8 and 93.2%, respectively). We could not find clinical correlation between either TIB less than 90% or lowest SpO 2 and LVMI.
Discussion
In patient with resistant HTN, the secondary causes for HTN may play an important role, and many reports believe this hypothesis [4] . The value of this study is to detect how frequent the OSA is present in these patients with resistant HTN, where OSA was detected in 81% of the patients with resistant HTN.
The prevalence of cardiovascular problems like arrhythmias, myocardial infarction, heart failure, and pulmonary HTN is higher in HTN-associated OSA [43] .
Left ventricular function has been associated with morbidity and mortality, and this has been observed by Dursunoglu et al. [43] . Little data about the prevalence of left ventricular function in a group of Egyptian patients are present. Our study showed that OSA was a frequently encountered problem among patients with resistant HTN, as 80% of cases of resistant HTN had OSA. This is consistent with the results of Rodrigo et al. [1] We could not explain exactly the underlying causes of this pattern, but it might be owing to (a) common risk factors like obesity, where our study showed that RHTN/OSA have higher BMI and waist circumference than control group, and (b) we also observed that AHI, hypopnea, and low O 2 saturation with TIB less than 90% were all significant in RHTN/OSA patient group than controlled/OSA patient group. Friedman et al. [44] explained this as 'a higher apnea-hypopnea index that is proportional to a greater degree of fluid volume displacement from the legs into the neck overnight. Such overnight rostral fluid shift may play a major role in the genesis of upper airway obstruction during sleep'.
We observed that excessive daytime sleepiness does not have significant difference between resistant HTNwith OSA and controlled HTN with OSA,This is consistent with other studies [1, 53, 55] . This phenomenon needs further assessment and research to assess the underlying reasons. This observation has led to the concept that excessive daytime sleepiness as assessed by ESS may not be a sensitive indicator for prediction of OSA in patients with resistant HTN. At the same time, this aforementioned observation may cause the OSA to not be frequently diagnosed as many patients may not have excessive daytime sleepiness, and also for that reason, it leads Drager et al. [45] to conclude that 'low clinical suspicion for OSA in cardiovascular patients group including hypertensive patients should be considered.'
We observed in this study that STOP-BANG might be used as an accurate way to assess the possibility of OSA in patients with resistant HTN, as there was a significant difference between both groups.
This study has assessed the left ventricular function both systolic and diastolic by LVMI and E/e′ with tissue Doppler, respectively.
In this study, LVM and LVMI were higher in resistant HTN/OSA patients than controlled group and showed clinical significance.
LVH might be owing to one or more of the following factors: (a) high BP, (b) sympathetic overactivity, (c) nocturnal hypoxemia, (d) oxidative stress, and (e) endothelial dysfunction. A larger study population may be needed for proper explanation of LVH. We tried in this study to exclude as much as we could any other possible co-existing causes that may affect the LVM and increase the risk of diastolic dysfunction such as aortic stenosis, heart attack, diabetes, and systolic heart failure.
We found a positive correlation between degree of OSA and the severity of HTN, as AHI was of clinical significance between case and control groups. This is consistent with other reports [46, 47] .
This study assessed the diastolic dysfunction through E/e′, which is crucial in the guidelines for diastolic evaluation [46] . The ratio between early mitral inflow velocity and mitral annular early diastolic velocity (E/ e′) were measured and calculated.
Our findings through both E/E′ and tissue Doppler confirmed that there was no significant difference between RHTN/OSA and controlled HTN/OSA. This is in agreement with a study including a cohort of 500 patients done by Niroumand et al. [47] , where they assessed the diastolic dysfunction only by E/A without tissue Doppler, and no correlation was detected. To assess the diastolic dysfunction with grading, tissue Doppler is one of the crucial tools to predict mortality [48, 49] .
Therefore, into our study we did try to detect diastolic dysfunction by both E/e′ and tissue Doppler, either to prove or exclude its presence.
Other studies [50] [51] [52] [53] [54] showed an association between severity of OSA and diastolic dysfunction, although the only limiting factor for these study was the small number of patients included.
Many studies showed that treatment of OSA with CPAP can reduce BP [56] . We think that proper management of OSA in patients with resistant HTN plays an important role to decrease the possible complications.
We believe that we have many strength points in this study. First, this is the first study to be conducted in Egypt on resistant HTN associated with OSA. Second, we tried to exclude other causes that may affect diastolic dysfunction in these patients like arrhythmias heart failure and aortic stenosis. Third, this is the first paper to use using LVMI for assessment of left ventricular systolic function in Egyptian patients. Fourth, we did combine E/e′ with tissue Doppler for better assessment of diastolic function of left ventricle.
We think also this study has some limitations, including (a) sleep clinic referral may not reflect the actual pattern in population, and (b) to study properly study the pathophysiolgical effects of nocturnal hypoxemia on LVH or diastolic function, we need a larger number of patients.
Conclusion
This study showed that patients with resistant HTN with OSA have increased LVMI with no significant diastolic dysfunction seen compared with controlled HTN with OSA. In this cohort of patients, we could conclude that OSA does not cause significant diastolic dysfunction in hypertensive patients, but limited patient number may affect this conclusion.
Recommendations
(1) Further studies are needed on a large scale to estimate the prevalence of OSA in resistant HTN. Nil.
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